Code | Completion | Credits | Range | Language |
---|---|---|---|---|
F7AMSEAZ | KZ | 3 | 2P+2S | English |
The subject follows the subject of Health Technology Assessment. During the semester the student will get acquainted with specific types of analyzes (cost-effectiveness analysis, cost-benefit analysis, cost-benefit analysis), learn how to work with TreeAge and create meta-analyzes and Markov models. The student will further expand his / her knowledge of multi-criteria decision analysis.
Individual work on exercises - max. 10 points for each. That is max. 60 points
Concluding test of the substance during the semester (max. 40 points).
-Introduction to economic analysis. Conditions of credit. Overview of analyzes.
-Meta-analysis. Use of clinical data in HTA. Randomized and non-randomized controlled trials. Observation studies. RR, ODDS. Forest plot plot.
-Statistical data processing for HTA.
-Multi-criteria decision making - an overview of methods, gradual scheduling of weights, compliance and non-conformities.
-DALY, HYEa. MAFEIP.
-Cost analyzes.
-Siva Cost Assessment Instrument.
-Predictive models of financial analysis.
-Financial analysis indicators.
-DuPont pyramidal decomposition. Budget impact analysis.
-Modeling in HTA. Markov models.
-Use of Bayesian methods in HTA.
•Introduction to economic analysis. Conditions of credit. Overview of analyzes.
•Meta-analysis. Use of clinical data in HTA. Randomized and non-randomized controlled trials. Observation studies. RR, ODDS. Forest plot plot.
•Statistical data processing for HTA.
•Multi-criteria decision making - an overview of methods, gradual scheduling of weights, compliance and non-conformities.
•DALY, HYEa. MAFEIP.
•Cost analyzes.
•Siva Cost Assessment Instrument.
•Predictive models of financial analysis.
•Financial analysis indicators.
•DuPont pyramidal decomposition. Budget impact analysis.
•Modeling in HTA. Markov models.
•Use of Bayesian methods in HTA.
[1].HUNINK, M. G. Myriam. Decision making in health and medicine: integrating evidence and values. Second edition. Cambridge, United Kingdom: Cambridge University Press, 2014. ISBN 978-1-107-69047-9.
[2].Edlin, R., McCabe, C.: Cost Effectiveness Modelling for Health Technology Assessment, Springer International Publishing Switzerland, 2015. ISBN: 978-3-319-15743-6.
Attachment | Size |
---|---|
![]() | 1.22 MB |
![]() | 365.02 KB |
![]() | 1.44 MB |
![]() | 3.58 MB |
![]() | 607.17 KB |
![]() | 382.58 KB |
![]() | 6.99 MB |
Attachment | Size |
---|---|
![]() | 495.49 KB |
![]() | 17.84 KB |
![]() | 59.05 KB |
![]() | 484.52 KB |
![]() | 11.26 KB |
![]() | 14 KB |
![]() | 11.46 KB |
![]() | 265.5 KB |
![]() | 14.81 KB |
Meta-analyst: http://www.cebm.brown.edu/openmeta/
Fixed vs random effects models in MA - short description: chapter from book "Introduction to Meta-Analysis"